Latest Supply Contracts News

Vulcan Energy has officially started full-scale construction of its Lionheart lithium chemicals facility in Frankfurt, targeting a 2028 commercial production start with a capacity to supply 500,000 EV batteries annually.

Papyrus Australia (ASX: PPY) has secured $175,000 through a share placement alongside convertible note conversions and related party loans, aiming to fund commercialisation and fulfil a key contract for biodegradable Collar Keeper® products.

Vault Minerals delivered 78,578 ounces of gold in the March quarter at an AISC of A$3,006/oz, generating a remarkable $229 million in underlying free cash flow. The company completed the first stage of its King of the Hills plant upgrade and declared a maiden dividend, reinforcing its position as a high-yielding gold producer.

Sunrise Energy Metals has confirmed strong economics for its Syerston Scandium Project with a US$120 million feasibility study, targeting 60 tonnes per year of scandium oxide and potential expansion to 180 tonnes. The project benefits from US government financing interest and rising global demand amid Chinese export restrictions.

Boab Metals has secured a six-year diesel supply deal with Cambridge Gulf subsidiary CGL Fuel, ensuring fuel reliability for Sorby Hills as it advances toward production in late 2027.

Green360 Technologies has produced its first commercial batch of Eco-Clay under a tolling deal with Calix, advancing its low-carbon cement alternative towards market entry in Victoria by mid-2026.

Vulcan Energy has locked in a €40 million framework agreement with Siemens to supply critical automation and engineering systems for its Lionheart lithium project in Germany, marking the final major contract ahead of production.

Atomo Diagnostics has responded to ASX queries confirming it first held market-sensitive information after Lumos Diagnostics’ FDA CLIA waiver approval for FebriDx. The company defended its trading halt and capital raise timing, asserting full compliance with ASX Listing Rules.

Botanix Pharmaceuticals has agreed to terms with Piramal to establish an alternate supplier for the active ingredient in Sofdra, aiming to reduce costs by up to 40% and strengthen its supply chain.

Aquirian’s Drillforce subsidiary has secured a $48 million, three-year drilling and blasting contract at Brightstar’s Lord Byron mine, marking a significant expansion of their strategic partnership in Western Australia’s Goldfields region.

Clarity Pharmaceuticals has secured a major manufacturing deal with Nucleus RadioPharma to produce its next-generation prostate cancer imaging agent, 64Cu-SAR-bisPSMA, ramping up supply ahead of anticipated US market entry.

Central Petroleum has secured a binding gas sales agreement with the Northern Territory Government, underpinning two new Palm Valley wells that could lift production capacity by around 40%. The deal replaces a prior arrangement and is supported by an expanded loan facility.